2-[(R)-[3,5-dimethyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并咪唑类
• 英文名称: 2-[(R)-[3,5-dimethyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole
• 化学式: C₁₇H₁₆F₃N₃O₂S
• 分子量: 383.4
• InChiKey: FPVRBOKLMQOBQO-AREMUKBSSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  26
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  87.1
• 氢给体数：
  1
• 氢受体数：
  8

文献信息

• Inhibitors of SARM1 NADase activity and uses thereof
  申请人：Washington University

  公开号：US11253503B2

  公开（公告）日：2022-02-22

  The present disclosure provides compounds useful as inhibitors of SARM1 NADase activity, compositions thereof, and methods of using the same. The present disclosure provides compounds useful for treating a neurodegenerative or neurological disease or disorder, compositions thereof, and methods of using the same.

  本公开提供了可用作 SARM1 NAD 酶活性抑制剂的化合物、其组合物及其使用方法。本公开提供了用于治疗神经退行性或神经疾病或紊乱的化合物、其组合物以及使用方法。
• INHIBITORS OF SARM1 NADASE ACTIVITY AND USES THEREOF
  申请人：WASHINGTON UNIVERSITY

  公开号：US20200129493A1

  公开（公告）日：2020-04-30

  The present disclosure provides compounds useful as inhibitors of SARM1 NADase activity, compositions thereof, and methods of using the same. The present disclosure provides compounds useful for treating a neurodegenerative or neurological disease or disorder, compositions thereof, and methods of using the same.
• CXCL10 Inhibitors
  申请人：LAPKO INC, dba AFECTA PHARMACEUTICALS

  公开号：US20220202796A1

  公开（公告）日：2022-06-30

  Provided herein are compounds and compositions effective for inhibiting CXCL10 gene expression, production, and secretion in mammalian cells, tissues and organs, as well as ameliorating its biological activity, along with a method for treatment of one or more disorders associated with an increase in CXCL10 gene expression, production, and secretion.